FLCCC COVID-19 Prevention & Early Outpatient Treatment Protocol

The FLCCC (Front Line COVID-19 Critical Care Alliance) developed a protocol using Ivermectin and supportive supplements for the prevention and early treatment of COVID-19. Ivermectin, a globally used anti-parasitic drug, has shown potential antiviral and anti-inflammatory properties. Though not FDA-approved for COVID-19, the NIH updated its stance to “neutral” in January 2021, allowing clinical discretion.

🛡️ Prevention Kit (Prophylaxis):

Contents:

Dosage Instructions:

• Ivermectin: 0.2 mg/kg per dose (with or after meals) — one dose on Day 1, repeat after 48 hours, then take once weekly.
• Vitamin D3: 1,000–3,000 IU daily
• Vitamin C: 500–1,000 mg twice daily
• Quercetin: 250 mg daily
• Zinc: 30–40 mg daily
• Melatonin: 6 mg before bedtime

🩺 Early Outpatient Treatment Kit:

Contents:

Dosage Instructions:

• Ivermectin: 0.2–0.4 mg/kg per day (with or after meals), once daily for 5 days or until recovered.
• Fluvoxamine: 50 mg twice daily for 10–14 days (avoid if patient is already on SSRI).
• Nasopharyngeal Hygiene: Steam inhalation 3x/day; gargle with chlorhexidine/benzydamine or use Betadine nasal spray 2–3x/day.
• Vitamin D3: 4,000 IU daily
• Vitamin C: 500–1,000 mg twice daily
• Quercetin: 250 mg twice daily
• Zinc: 100 mg daily
• Melatonin: 10 mg at bedtime
• Aspirin: 325 mg daily (unless contraindicated)

Note: Always consult a healthcare professional before initiating any medication or supplement protocol.